latest news releases from the newsroom
ViroPharma Incorporated Commences Exchange Offer for its 6% Convertible Subordinated Notes Due 2007
EXTON, Pa., April 28, 2004 (PRIMEZONE) -- ViroPharma Incorporated (Nasdaq:VPHM), a pharmaceutical company focused on developing and commercializing products that address serious diseases treated by physician specialists and in hospital settings, including cytomegalovirus (CMV) and hepatitis C (HCV), today announced that it commenced an offer to exchange up to $99,122,500 aggregate principal amount of its new 6% Convertible Senior Plus Cash Notes(SM) due 2009 for up to all of the $127,900,000 aggregate principal amount of its currently outstanding 6% Convertible Subordinated Notes. In addition, the Company is offering to the public an additional $25,000,000 of the new Convertible Senior Plus Cash Notes(SM), for cash.
Teleca chosen for MTC-Vodafone Kuwait
MALMO, Sweden, April 28, 2004 (PRIMEZONE) -- Teleca today announced a new contract to supply an inventory management system to MTC-Vodafone in Kuwait as part of a larger agreement with prime contractor Harris Corporation. Teleca will deploy the inventory management solution based on software from Cramer.
New Group function for environment at Boliden
STOCKHOLM, Sweden, April 28, 2004 (PRIMEZONE) -- New Boliden is continuing to consolidate its position in the fields of the work environment, the external environment, occupational healthcare and dam safety. The acquisition of Outokumpu's mining and smelting units at the turn of the year has led to a major injection of resources and know-how into Boliden's already strong and established environmental organisation.
Biacore Interim Report January - March 2004
UPPSALA, Sweden, April 28, 2004 (PRIMEZONE) -- Biacore's sales in the first quarter of 2004 amounted to SEK 95.3 million (106.5), a decline by 11%. Excluding the impact of exchange rates, sales increased by 2%. Encouragingly, the Americas saw its second quarter of positive sales development, as early-stage drug discovery customers resumed instrument purchases. This positive trend was also seen in Europe. The reported sales decline was entirely due to a disruption in purchasing patterns caused by a reorganization and de- centralization of academic research in Japan.